Prevention and control of carbapenemase- producing enterobacteriaceae
pdf

Keywords

bacteria
infection control
carbapenemase- producing enterobacteriaceae
infection prevention

Abstract

 

 

 

https://doi.org/10.48037/mbmj.v9i5.1421
pdf

References

World Health Organisation. Guidelines for the prevention and control of carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in health care facilities. Switzerland: WHO Document Production Services; 2017.

Weston D. Infection prevention and control. Theory and practice for Healthcare Professionals. Chichester: Wiley; 2008.

UK Health Security Agency. Quarterly laboratory surveillance of acquired carbapenemase-producing Gram-negative bacteria in England: October 2020 to December 2022. Health Protection Report, 2023;17(4)

Otter JA, Burgess P, Davies F. Counting the cost of an outbreak of carbapenemase-producing Enterobacteriaceae: an economic evaluation from a hospital perspective. Clin Microbiol Infect. 2016;23(3):188-196. Available from: https://doi.org/10.1016/j.cmi.2016.10.005

Savard P, Perl TM. Combating the spread of carbapenemases in Enterobacteriaceae: a battle that infection prevention should not lose. Clin Microbiol Infect. 2014;20(9):854-61. Available from: https://doi.org/10.1111/1469-0691.12748

Hughes LD, Aljawadi A, Pillai A. (2019). An overview of carbapenemase producing enterobacteriaceae (CPE) in trauma and orthopaedics. 2019;16(6):455-458. Available from: https://doi.org/10.1016/j.jor.2019.06.026

UK Health Security Agency. (2022). Framework of actions to contain carbapenemase-producing Enterobacterales. Available at: https://www.gov.uk/government/publications/actions-to-containcarbapenemase-producing-enterobacterales-cpe (accessed 30 March 2023)

Heymann D, Dar O. (2014). Prevention is better than cure for emerging infectious diseases. BMJ. ;348:g1499. Available from: https://doi.org/10.1136/bmj.g1499

European Centre for Disease Prevention and Control. Risk assessment on the spread of carbapenemase-producing Enterobacteriaceae (CPE) through patient transfer between healthcare facilities, with special emphasis on cross-border transfer. Stockholm: ECDC; 2011.

Wilson J. Infection control in clinical practice. 3rd ed. Oxford: Elsevier; 2019.

Oliver D. Should single rooms be the default for NHS inpatients? BMJ.2021;375:n2612. Available from: https://doi.org/10.1136/bmj.n2612

Soria-Segarra C, Soria-Segarra C, Catagua-Gonzalez A, Gutierrez-Fernandez J. Carbapenemase producing Enterobacteriaceae in intensive care units in Ecuador: Results from a multicentre study. J Infect Public Health. 2020;13(1):80-88. Available from: https://doi.org/10.1016/j.jiph.2019.06.013

Welch A. Superbug CRE a growing threat among young children. Available at: https://www.cbsnews.com/news/superbug-cre-growing-threat-among-young-children/#:~:text=Specifically%2C%20the%20results%20showed%20that,rate%20increased%20from%20zero%20to%20. 2015 (accessed 03 June 2023).